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A 29-year-old woman presented to the Fondazione IRCCS “Ca` Granda” Ospedale Maggiore, a tertiary care university hospital in
Milan (Italy), with skin lesions, fever, myalgia, joint pain and swelling, and a one-week history of low back pain. The diagnosis
was Staphylococcus aureus (S. aureus) bacteraemia spreading to skin, bones, and joints and a lumbosacral epidural abscess L5-S2.
Neither initial focus nor predisposing conditions were apparent. The antibiotic therapy was prolonged for six-weeks with the
resolution of fever, skin lesions, articular inflammation, and the epidural abscess. Community-acquired S. aureus infections
can aﬀect patients without traditional healthcare-associated risk factors, and community acquisition is a risk-factor for the
development of complications. Raised awareness of S. aureus bacteraemia, also in patients without healthcare-associated risk
factors, is important in the diagnosis, management, and control of this infection, because failure to recognise patients with serious
infection and lack of understanding of empirical antimicrobial selection are associated with a high mortality rate in otherwise
healthy people.
1. Introduction
Rates of Staphylococcus aureus (S. aureus) bacteraemia re-
main high around the world and represent a significant
healthcare burden. In the United States, excess costs, length
of hospitalisation, and inpatient deaths due to S. aureus are
estimated at $9.5 billion, 2.7million days, and 12 000 patients
per year, respectively [1].
Community-acquired S. aureus infections can aﬀect pa-
tients with few or without traditional healthcare-associated
risk factors, and community acquisition is a risk-factor for
the development of complications [2].
In spite of advances in medical care and discovery of
potent antistaphylococcal antibiotics, about a third of pa-
tients with S. aureus bacteraemia die within 30 days [3]. The
risk of death is similar for methicillin sensitive and methi-
cillin resistant S. aureus infections [4]. The most critical
determinants of survival and reduction of complications are
an early identification of bloodstream infections, combined
with the induction of timely and appropriate antibiotic
therapy [2]. Early recognition, prompt initiation of appro-
priate antibiotics, and rapid microbiological diagnosis are,
therefore, key components of eﬀective clinical management.
Raised awareness of S. aureus bacteraemia, also in pa-
tients without healthcare-associated risk factors, is important
in the diagnosis, management, and control of this infection,
because failure to recognise patients with serious infection
and lack of understanding of empirical antimicrobial selec-
tion are associated with a high mortality rate.
2. Case Presentation
A 29-year-old previously healthy woman was admitted to
Emergency Department because of sudden appearance and
spreading of skin lesions, fever, myalgia, joint swelling, and
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Figure 1: Skin vesiculobullous lesions on left leg.
Figure 2: Skin lesions on left palm and on third finger.
a painfully decreased range of joint motion. She had one-
week history of low back pain for which her physician pre-
scribed a three-day course of intramuscular nonsteroidal
anti-inflammatory drug (NSAID).
The patient was overweight (bodymass index, BMI = 44),
her medical history was unremarkable, she did not have toxic
habits and she had no travelled abroad. On admission to our
Department blood pressure was 110/80mmHg, pulse 120
beats per minute, temperature 38.5◦C. On physical examina-
tion, she presented vesiculobullous lesions (Figure 1) mostly
located on her trunk and extremities, including palms and
soles (Figure 2). None were seen on her lips or oropharynx.
An asymmetric arthritis of her left elbow, wrist and
metacarpophalangeal joints (Figure 3), right ankle, and
first metatarsophalangeal joint was present. The sites of
the previous intramuscular injections were undetectable.
Leukocytosis (white blood cell count 27.5 × 109 cells/L with
91% Neutrophils) elevated level of lactic dehydrogenases,
transaminases, alkaline phosphatase, and raised C-reactive
protein concentration were found. A chest X-ray revealed
no evidence of pulmonary disease, and an electrocardiogram
was normal.
Given the clinical picture, strongly suspected for systemic
infection, empirical antibiotic treatment was started after
Figure 3: Metacarpal-phalangeal arthritis of the left hand.
microbiological studies, and intravenous ceftriaxone admin-
istered at 2 g per day.
Serologic tests were negative for acute viral infections
(hepatitis, epstein-barr, cytomegalovirus, herpes zoster and
simplex viruses, and HIV included), rickettsiosis, and borre-
liosis.
A methicillin susceptible S. aureus was isolated from
blood and aspirate of fluid from bullae.
An epidural soft extra-mass, highly intense to T2 sig-
nal nuclear magnetic resonance (NMR) imaging, brightly
enhanced by gadolinium injection, was seen to adhere the
spinal cord close to L5-S2 associated to a very beginning
spondylodiscitis L5-S1 (Figure 4).
A transesophageal echocardiography showed a normal
ejection fraction and no evidence of valvular disease or vege-
tations suggestive of endocarditis.
The patient was diagnosed with S. aureus bacteraemia
spreading to skin, bones, and joints and a lumbosacral epidu-
ral abscess L5-S2.
Fever disappeared, and skin lesions cleared up in a week,
but antibiotic therapy was prolonged for six weeks consider-
ing the spread over of the infection and the epidural abscess.
No neurological signs manifested, and the articular inflam-
mation gradually subsided. NMR imaging evaluation was
performed every two weeks until the resolution of epidural
abscess. Plain X-rays of the involved joints after symptoms
resolutions did not show joint destructive changes.
3. Discussion
S. aureus bacteraemia is common and increasing worldwide
and is associated with substantial morbidity and mortality.
It is often associated with a local focus of infection that has
gained access to the bloodstream but in about one-third of
patients (notably in community acquired cases), no initial
focus is apparent.
Fever and severe myalgias are usually present in symp-
tomatic cases, and overt septic shock may develop. Oth-
erwise, low-grade bacteraemia leading to seeding of heart
valves or other sites may be totally asymptomatic. Metastatic
infections usually result from haematogenous seeding of
a deep site (e.g., endocarditis, septic arthritis, splenic abscess,
spondylodiscitis, and skin/soft tissue), may be clinically
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Figure 4: Sagittal T2-weighted, gadolinium-enhanced NMR imag-
ing demonstrates enhancing epidural collection ventrally compress-
ing the thecal sac opposite the L5-S2 vertebrae. The L5-S1 disk space
is partially obliterated and the bony end plates enhanced, reflecting
discitis and osteomyelitis.
obvious or may be occult and totally asymptomatic, and can
manifest early in the illness or weeks later.
The presence of S. aureus bacteraemia does not, in and
of itself, establish the source of infection, because S. aureus is
also the cause of a number of mimicking conditions such as
osteomyelitis, discitis, sepsis, and endocarditis.
The disease of our patient fitted the Center for Disease
Control (CDC) definition for community acquisition [5],
because MSSA was diagnosed in an outpatient with no
history of hospitalization in the past year, or surgery, or other
form of hospital-facilities care, no indwelling catheters, or
medical devices carrier.
The bacterial infection of the skin was the reason to seek
medical advice and were an eﬀect of the bloodstream infec-
tion spreading.
The primary and most important step in the assessment
of a patient with S. aureus bacteraemia is defining the extent
of infection, as this will determine the nature of manage-
ment. A very active search for all complicating infectious
foci should be recommended, since 32% of complicating
infectious foci did not have guiding signs and symptoms
and 10% are first diagnosed at autopsy. Infection-related
mortality is 29% in patients with complicating infectious foci
[6].
Factors associated with the development of complicating
infectious foci or high mortality are a delay in treatment for
more than 48 h after the onset of symptoms, community
acquisition, persistently positive blood cultures, persistent
fever, congenital heart disease, and the presence of foreign
bodies or prosthetic valves and underlying conditions such
as immunosuppression and malignancy [6].
The BMI of our patient was 44. Obesity has not been
demonstrated as a risk factor for community acquisition of
S. aureus bacteraemia, while a recent study showed that ob-
esity, together with smoking, constitutes an important risk
factor for case fatality in bacteraemic patients [7].
The low back pain complained first by the patient could
be the initial manifestation of the epidural abscess. Spinal
epidural abscess is a rare but serious cause of back pain. Clas-
sical clinical triad consists of back pain, fever, and neurologic
deficit, but it is not always present. Clinical picture is often
nonspecific, and physicians can attribute back pain to other
more frequent infectious (osteomyelitis, meningitis, urinary
tract infections) or noninfectious conditions, as was the case
of this patient [8]. The clinical signs and symptoms are sub-
tle, vague, and insidious. High level of awareness is required
by physicians in order to making the correct diagnosis in
the early stage of disease to avoid the severely debilitating
complications from delayed or inadequate treatment.
Bacteria gain access to the epidural space through con-
tiguous spread (about one third of cases) or haematogenous
dissemination (about half of cases); in the remaining cases,
the source of infection is not identified. Predisposing factors
include spinal surgery, intravenous drug use, immunosup-
pression, and epidural catheterism; however, in up to one
third cases, no risk factors are present. Because most predis-
posing conditions allow for invasion by skin flora, S. aureus
causes about two thirds of cases of spinal epidural abscess
[9]. Likewise, infection that originates in the spinal epidural
space can extend locally or through the bloodstream to other
sites. Discitis and osteomyelitis coexist with spinal epidural
abscess in up to 80% of patients [10]. The incidence of acute
haematogenous nontuberculous vertebral osteomyelitis was
estimated to be five cases per million patients per year [11].
NMR imaging with intravenous administration of gado-
linium and myelography is the imaging method of choice
with more than 90% sensitivity in diagnosing spinal epidural
abscess and is especially useful in the early stages of infection
when other imaging modalities are still normal (radiog-
raphy). It delineates both the longitudinal and paraspinal
extension of the abscess and may help diﬀerentiate infection
from cancer on the basis of the appearance and the signal
intensity of the image [12]. A plain roentgenograph or CT-
scan of the spine may reveal narrowing of the disk and bone
lysis to indicate the presence of discitis and osteomyelitis.
Patients with S. aureus bacteraemia can develop sec-
ondary septic arthritis, particularly if an underlying joint
disease such as rheumatoid arthritis is present. The joints
aﬀected, in decreasing order of frequency, are the knee, hip,
elbow, shoulder, and interphalangeal joint. The arthrocen-
tesis to evaluate for septic arthritis was not performed in
the patient we described, and then, the infectious etiology of
arthritis was not demonstrated. Thus, the patient presented
polyarticular arthritis and no underlying joint disease such
as rheumatoid arthritis was present, suggesting a diﬀerent
etiology. Induction of arthritis during S. aureus infection
might be also triggered by the concerted action of both su-
perantigens activating T lymphocytes and exposure to pepti-
doglycans/capsular polysaccharides and free bacterial DNA
(originating from disrupted bacteria) triggering macro-
phages to release proinflammatory cytokines [13].
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Patients presenting with S. aureus bacteraemia compli-
cated bymetastatic infection will require prompt intravenous
administration of appropriate antibiotics that should be
prolonged for 4 to 6 weeks. Surgery is mandatory if neuro-
logical dysfunction develops in patients with spinal epidural
abscess. Otherwise, antibiotic therapy alone and close fol-
lowup is a valuable choice if the microbial cause is identified
and the patients’ clinical condition is closely monitored [14].
Neurologic function, signs of sepsis, and imaging findings
should be closely monitored after treatment begins. A neuro-
logic deterioration between admission and accurate diagno-
sis may lead to a poorer outcome [15].
The inability to rapidly identify and characterise in-
fecting organisms means that initial antibiotic therapy
is often empirical. This may result in inappropriate treat-
ment, which is associated with extended overall dura-
tion of hospitalisation, increased risk of patient mortal-
ity and increased overall cost of treatment particularly
for patients infected with methicillin-resistant S. aureus.
The traditional approach to treatment of staphylococcal
infections is to prescribe first generation cephalosporins
(cefazolin, cephalothin, and cephalexin), clindamycin, lin-
comycin, and erythromycin for outpatients in less serious
methicillin-susceptible S. aureus infections such as skin
and soft tissue infections. Penicillinase-resistant penicillins
(flucloxacillin and dicloxacillin) remain the antibiotics of
choice for the management of serious methicillin-susceptible
S. aureus infections for patients requiring hospitalization
and vancomycin for patients with β-lactam allergies or
methicillin-resistant strains of S. aureus [16, 17]. How-
ever, with the emergence and increasing prevalence of com-
munity-associated methicillin-resistant strains [18], some
of these choices may need reconsideration. From a clinical
standpoint, given the morbidity and mortality associated
with delayed treatment of MRSA infection, it would be
prudent to include methicillin-resistant S. aureus coverage in
empirical antibiotic regimens in settings where a significant
proportion of patients hospitalized for community-acquired
S. aureus infection have methicillin-resistant strains.
A recent review focusing on the evidence behind the key
clinical decisions in the management of S. aureus bacter-
aemia highlights just two key principles; that is, all infective
foci must be identified and removed as soon as possible,
and long-term antimicrobial therapy is required for those
with persistent bacteraemia or a deep, irremovable focus. The
best drugs, dose, mode of delivery, and duration of therapy
remained uncertain, a situation compounded by emerging S.
aureus strains that are resistant to old and new antibiotics
[19].
New management strategies are required including the
use of techniques that allow the early identification of com-
plications arising from S. aureus bacteraemia, rapid pathogen
identification to enable the administration of appropriate
antibiotic therapy, and the identification of new drugs that
enable eﬀective empirical treatment against both susceptible
and resistant S. aureus.
Finally, the clinician is again reminded that S. aureus can
cause severe life-threatening infections in otherwise healthy
people.
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